Endothelial Dysfunction: Clinical Trials

4 trials for Endothelial Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 11Unknown 1

Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
Imatinib, Compound sodium lactate solution - Sepsis, Fluid Overload
Phase 1 / Phase 2UnknownBelfast Health and Social Care Trust652024-12-012024-10-04
n-3 PUFA for Vascular Cognitive Aging
Omega 3 PUFA, Placebo - Age Related Cognitive Decline, Alzheimer's Disease
Phase 2UnknownOregon Health and Science University1022014-05-012020-09-04
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
Intensive multifactorial group, conventional multifactorial therapy group - Endothelial Dysfunction
Phase 2UnknownXiang Guang-da10002010-04-012013-07-08
Vascular Effects of Hesperidin in Metabolic Syndrome
Hesperidin, Placebo - Endothelial Dysfunction, Metabolic Syndrome
Phase 2UnknownUniversity of Rome Tor Vergata302008-11-012009-06-17

Narrower conditions

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Dementia, Vascular (1)  ·  Edema (1)  ·  Metabolic Syndrome (1)  ·  Sepsis (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Cognition Disorders (1)  ·  Dementia (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Intracranial Arterial Diseases (1)  ·  Intracranial Arteriosclerosis (1)

Interventions

Fish Oils (1)  ·  Hesperidin (1)  ·  Imatinib Mesylate (1)  ·  Ringer's Lactate (1)  ·  Soybean Oil (1)

Sponsors

Belfast Health and Social Care Trust (1)  ·  Oregon Health and Science University (1)  ·  University of Rome Tor Vergata (1)  ·  Xiang Guang-da (1)

Countries

China (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Gene Bowman, ND, MPH (1)  ·  Lynne Shinto, ND, MPH (1)  ·  Xiang Guangda, MD.Ph D (1)

Results publications

PMID 21346065, PMID 30934894, PMID 39088212

NIH funding

R01AG043398 (1)